Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications.
In the past decade our understanding of idiosyncratic drug induced liver injury (IDILI) and the contribution of genetic susceptibility and the adaptive immune system to the pathogenesis of this disease process has grown tremendously. One of the characteristics of IDILI is that it occurs rarely and only in a subset of individuals with a presumed susceptibility to the drug. Despite a clear association between single nucleotide polymorphisms in human leukocyte antigen (HLA) genes and certain drugs that cause IDILI, not all individuals with susceptible HLA genotypes develop clinically significant liver injury when exposed to drugs. The adaptation hypothesis has been put forth as an explanation for why only a small percentage of susceptible individuals develop overt IDILI and severe injury, while the majority with susceptible genotypes develop only mild abnormalities that resolve spontaneously upon continuation of the drug. This spontaneous resolution is referred to as clinical adaptation. Failure to adapt or defective adaptation leads to clinically significant liver injury. In this review we explore the immuno-tolerant microenvironment of the liver and the mechanisms of clinical adaptation in IDILI with a focus on the role of immune-tolerance and cellular adaptive responses.
Research Center for Liver Disease, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Lily
L
Dara
Research Center for Liver Disease, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Zhang-Xu
ZX
Liu
Research Center for Liver Disease, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Neil
N
Kaplowitz
D000222:Adaptation, Physiological / Q000235:genetics / Q000276:immunology; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000276:immunology / Q000503:physiopathology; D020022:Genetic Predisposition to Disease; D006680:HLA Antigens / Q000235:genetics*; D006801:Humans; D007108:Immune Tolerance; D012720:Severity of Illness Index
D006680:HLA Antigens
T cells; drug induced liver injury; hepatotoxicity; human leukocyte antigen; immune-tolerance